Prevention trials in Alzheimer's disease: Design issues

被引：0
|
作者：
Thal, L [1 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80310-5
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
下载
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [21] Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives
    Wang, Jun
    Tan, Lan
    Yu, Jin-tai
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 50 (04) : 927 - 945
  • [22] Alzheimer’s Disease Clinical Trials: Moving Toward Successful Prevention
    Michael S. Rafii
    Paul S. Aisen
    CNS Drugs, 2019, 33 : 99 - 106
  • [23] Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials
    Aschenbrenner, Andrew J.
    Hassenstab, Jason
    Wang, Guoqiao
    Li, Yan
    Xiong, Chengjie
    McDade, Eric
    Clifford, David B.
    Salloway, Stephen
    Farlow, Martin
    Yaari, Roy
    Cheng, Eden Y. J.
    Holdridge, Karen C.
    Mummery, Catherine J.
    Masters, Colin L.
    Hsiung, Ging-Yuek
    Surti, Ghulam
    Day, Gregory S.
    Weintraub, Sandra
    Honig, Lawrence S.
    Galvin, James E.
    Ringman, John M.
    Brooks, William S.
    Fox, Nick C.
    Snyder, Peter J.
    Suzuki, Kazushi
    Shimada, Hiroyuki
    Graeber, Susanne
    Bateman, Randall J.
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [24] Imaging the Onset and Progression of Alzheimer's Disease: Implications for Prevention Trials
    Liang, Yuying
    Ryan, Natalie S.
    Schott, Jonathan M.
    Fox, Nick C.
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 : S305 - S312
  • [25] Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease
    de Aquino, Camila Henriques
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [26] Methodological issues in the design of primary prevention trials
    Gaziano, JM
    Hennekens, CH
    Buring, JE
    CHEMOPREVENTION IN CANCER CONTROL, 1996, (136): : 7 - 12
  • [27] Neuroprotective trials in Parkinson's disease: Design issues and prospects
    Kieburtz, K
    MOVEMENT DISORDERS, 2004, 19 : S9 - S9
  • [28] Status of primary prevention trials in Alzheimer disease
    Thal, L
    NEUROBIOLOGY OF AGING, 2006, 27 : S21 - S21
  • [29] Double placebo design in a prevention trial for Alzheimer's disease
    Martin, BK
    Meinert, CL
    Breitner, JCS
    CONTROLLED CLINICAL TRIALS, 2002, 23 (01): : 93 - 99
  • [30] Disease modifying trials in Alzheimer disease: Methodological and statistical issues
    Andrieu, S
    Rascol, O
    Lang, T
    Grandjean, H
    Vellas, B
    JOURNAL OF NUTRITION HEALTH & AGING, 2006, 10 (02): : 116 - 117
12345